Vontier Corp (VNT) stock analysis
Close on Nov 11, 2026Market cap $5.92BP/E –Yield 0.23%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed11 of 30 checks passed
Vontier passes 11 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 2/6
- Growth
- 1/6
- Past performance
- 1/6
- Financial health
- 4/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 21.7% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $43.78 is below our fair value estimate of $55.90.
Return on capital over 10%
Return on invested capital was 15.8%, above the 10% that usually covers the cost of capital.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 26.1% of total debt.
What to watch
High debt
Debt is 157% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 3.5% a year over the last three fiscal years.
EV/EBITDA above its 5-year median
Vontier's EV/EBITDA of 11.9 is above its 5-year median of 11.7.
Valuation2/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA above its 5-year median
Vontier's EV/EBITDA of 11.9 is above its 5-year median of 11.7.
P/B above the industry
Vontier's price-to-book of 4.89 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading below fair value
The share price of $43.78 is below our fair value estimate of $55.90.
Margin of safety over 20%
The price is 21.7% below fair value, more than the 20% cushion we look for.
Growth1/6
Revenue growing under 10% a year
Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 3.5% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 0.3% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance raised
Vontier raised its 2026 Outlook Total sales outlook on Aug 6, 2026.
Gross margin trend
This company does not report gross profit.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 15.8%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health4/6
High debt
Debt is 157% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 968% five years ago to 157%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 26.1% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.23 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.27; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Vontier paid dividends worth 0.2% of the share price over the last twelve months.
Yield below Treasuries
The 0.2% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Vontier yields 0.2%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 5 fiscal years.
Earnings cover
Needs dividends paid and net income.
Covered by free cash flow
Dividends take 3.4% of free cash flow.
Fair value
How we estimate itOur estimate per share
$55.90
The share price is 22% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 17.6× | 11.7× | 23.7× | $71.03 | 58% |
| P/B | 4.6× | 6.1× | 3.2× | $41.44 | 17% |
| Earnings power | 10.2% cost of equity | – | – | $30.25 | 25% |
| Fair value | $55.90 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- EV/EBITDA at month end
- Own 5-year median 11.7
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 23.7
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $56.72M
- Value traded per 1% price move
- $33.25M
Downside
Medium risk
- Typical loss in a bad month
- 21.9%
- Volatility (annualized)
- 31%
- Sharpe ratio, 1 year
- 0.36
- Beta to the S&P 500 (5Y)
- 1.06
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2017 to 2025
Gross margin
Operating margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +3.2% | -1.2% | +2.6% | – | |
| Operating income | +4.6% | -0.9% | +3.7% | – | |
| EPS, diluted | +0.4% | +3.5% | +6.4% | – | |
| Free cash flow | +27.9% | +19.1% | -7.6% | – | |
| Dividend per share | 0.0% | +58.7% | – | – |
Returns and balance sheet
9 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Current ratio | – | 1.41 | 1.16 | |
| Debt to equity | – | 9.68 | 1.68 | |
| Net debt to EBITDA | – | 2.63× | 2.62× | |
| Interest coverage | – | 79.4× | – | |
| Inventory turnover | – | 6.6× | – | |
| Capex to revenue | – | 1.3% | 2.3% | |
| Diluted shares | – | 169M | 147M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Vontier generated $2.20B from operations and spent $1.32B on capital expenditure, dividends and share buybacks. 24% of that went back into the business.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$511.00M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$511.00M vs –
- Less leverageLong-term debt to assets fell48.5% → 36.5%
- Better liquidityCurrent ratio rose1.51 → 1.16
- No dilutionShare count did not rise154M → 147M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.69 → 0.71
See a number that looks wrong?